Fundz

Fundz Deep Dive

Everything you need to win Chris Mathes — in one platform.

Who to reach, what to say, and why now on Chris Mathes — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Chris Mathes — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Metrion Biosciences Appoints Lee Patterson As CEO, Dr Chris Mathes As CCO

PRIVATENov 25, 2024•over 1 year ago

Position

Chief Communications Officer

Company

Metrion Biosciences

Chris Mathes
CambridgeBiotechnology

Description

Metrion Biosciences has appointed Lee Patterson as its new CEO, effective from 2nd December 2024. Lee Patterson will guide the company in executing an ambitious growth strategy, while Dr Chris Mathes has been appointed as the latest CCO to bolster the company's global commercial presence and scientific capabilities.

Company Information

Company

Metrion Biosciences

Location

Cambridge, Maryland, United States

About

Metrion is a specialist ion channel contract research organisation (CRO) and drug discovery company dedicated to advancing biosciences. The company has experienced significant growth and aims to continue its expansion in the industry.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Metrion Biosciences's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.